Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

被引：0
|
作者：
Panagiotou, E. [1 ]
Livanou, M. E. [1 ]
Montgomery, A. [2 ]
Mastrogeorgiou, M. [1 ]
Moeckel, C. [2 ]
Syrigos, N. [1 ]
Mouratidis, I. [2 ]
Charpidou, A. [1 ]
Georgakopoulos-Soares, I. [2 ]
Vathiotis, I. [1 ]
机构：
[1] Sotiria Thorac Dis Hosp Athens, Med Oncol, Athens, Greece
[2] Penn State Coll Med, Biochem & Mol Biol, Hershey, PA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1238
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2007P
引用
收藏
页码：S1069 / S1069
页数：1
相关论文
共 50 条
  • [1] Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
    Elijah, Joseph
    Jain, Prantesh
    Holdsworth, Allison
    Baron, Jeffrey
    Przespolewski, Eugene
    Wang, Katy
    Attwood, Kristopher
    Billias, Christina
    Dy, Grace K.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (09)
  • [2] Adoption and early clinical outcomes of atezolizumab (atezo) plus carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
    Tsui, D. C. C.
    Polito, L.
    Madhavan, S.
    Adler, L.
    Ogale, S.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2021, 32 : S1164 - S1164
  • [3] Anlotinib combined with chemotherapy in the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC): A real-world study
    Gao, F.
    Zhao, Y.
    Li, X.
    Li, Y.
    Ma, T.
    Li, Q.
    Tang, X.
    Han, X.
    Yi, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1069 - S1069
  • [4] Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
    Xiang, Y.
    Tang, Y.
    Luan, T.
    Mengchen, L.
    Shi, W.
    Chin, A. G. W.
    Feng, X.
    Wang, F.
    Sun, X. W.
    Bao, Z.
    Zhou, J.
    Zhao, J.
    Wu, H.
    Fu, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S1666 - S1667
  • [5] Real-World Outcomes of Platinum-immunotherapy as First-Line (1L) Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ganti, A. K.
    Prince, T.
    Back, S.
    Chansakul, A.
    Boccuti, A.
    Rengarajan, B.
    Chakrabarti, D.
    Li, W.
    Fan, L.
    Cao, Y.
    D'Agostino, R., Jr.
    Fan, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S664 - S665
  • [6] Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy
    Wang, Yang
    Mathai, Jared
    Alamgeer, Muhammad
    Parakh, Sagun
    Paul, Eldho
    Mitchell, Paul
    Arulananda, Surein
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (08):
  • [7] Non-invasive radiomics signature predicts response to combination chemoimmunotherapy in extensive-stage small cell lung cancer (ES SCLC)
    Perimbeti, S.
    Khorrami, M.
    Viswanathan, V. S.
    Zia, M.
    Gupta, A.
    Roche, C. L.
    Barrera, C.
    Trivedi, H.
    Behera, M.
    Higgins, K.
    Jain, P.
    Madabhushi, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1070 - S1070
  • [8] Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
    Goldschmidt, Jerome
    Hart, Lowell
    Scott, Jeffrey
    Boykin, Kristen
    Bailey, Ray
    Heritage, Trevor
    Lopez-Gonzalez, Lorena
    Zhou, Zheng-Yi
    Edwards, Marie Louise
    Monnette, Alisha
    Ogbonnaya, Augustina
    Deyoung, Kathryn
    Venkatasetty, Divea
    Shi, Ping
    Aton, Lindsay
    Huang, Huan
    Conkling, Paul. R. R.
    Gordan, Lucio
    ADVANCES IN THERAPY, 2023, 40 (10) : 4189 - 4215
  • [9] Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients
    Ullah, A. T.
    Quintanilha, J.
    Graf, R.
    Oxnard, G.
    Riess, J. W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S367 - S368
  • [10] Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
    Jerome Goldschmidt
    Lowell Hart
    Jeffrey Scott
    Kristen Boykin
    Ray Bailey
    Trevor Heritage
    Lorena Lopez-Gonzalez
    Zheng-Yi Zhou
    Marie Louise Edwards
    Alisha Monnette
    Augustina Ogbonnaya
    Kathryn Deyoung
    Divea Venkatasetty
    Ping Shi
    Lindsay Aton
    Huan Huang
    Paul R. Conkling
    Lucio Gordan
    Advances in Therapy, 2023, 40 : 4189 - 4215
12345